Research progress on the protective effect and mechanism of puerarin on diabetic retinopathy
Author:
Fund Project:

National Natural Science Foundation of China(No.82260212)

  • Article
  • | |
  • Metrics
  • |
  • Reference [44]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Increasing prevalence and incidence of diabetes mellitus(DM)-the most common chronic consumptive disease worldwide-has a devastating impact on people's daily lives, particularly through the deterioration or complete loss of vision brought on by diabetic retinopathy(DR). Therefore, it is imperative to investigate the pathogenesis and effective treatment of DR. Meanwhile, Pueraria lobata is the extensively used dried root of kudzu or dried kudzu, also known as Pueraria flavonoids. Moreover, its roots are primarily composed of isoflavones, Pueroside ABC, triterpenes, and alkaloids, which can calm cardio-cerebrovascular smooth muscle and enhance microcirculation. Currently, it is widely employed for the treatment of cardio-cerebrovascular diseases, osteonecrosis, DM and its complications, neurodegenerative disorders, endometriosis and tumor diseases. Inhibiting retinal neovascularization, alleviating ischemia and hypoxia, decreasing advanced glycation end products in diabetes, raising insulin-like growth factor(IGF)expression while decreasing tumor necrosis factor-α(TNF-a)expression, decreasing vascular endothelial growth factor(VEGF)expression, reducing retinal nerve cell death, inhibiting the NOD-like receptor protein 3(NLRP3)inflammatory pathway and inhibiting ferroptosis are all mechanisms by which puerarin(Pue)has been found to protect the retina in recent studies. Thus, this article summarizes the current comprehension of the mechanism and protective effect of Pue on diabetic retina, serving as a guidepost for its future development and application.

    Reference
    1 Chiu PY, Chen N, Leong PK, et al. Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in H9c2 cells. Mol Cell Biochem 2011; 350(1):237-250
    2 凌志红, 徐格致, 龚红华, 等. 糖基化终产物对纯化培养大鼠视网膜神经节细胞凋亡的影响. 中华眼科杂志 2005; 41(1):55-57
    3 Mounirou BAM, Adam ND, Yakoura AKH, et al. Diabetic retinopathy: an overview of treatments. Indian J Endocrinol Metab 2022; 26(2):111-118
    4 Putta S, Yarla NS, Kilari EK, et al. Therapeutic potentials of triterpenes in diabetes and its associated complications. Curr Top Med Chem 2016; 16(23):2532-2542
    5 Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010; 376(9735):124-136
    6 Madsen-Bouterse SA, Zhong Q, Mohammad G, et al. Oxidative damage of mitochondrial DNA in diabetes and its protection by Manganese superoxide dismutase. Free Radic Res 2010; 44(3):313-321
    7 姜萌萌, 柳林, 张敬法. 神经元退行性病变在糖尿病视网膜病变中的研究进展. 国际眼科杂志 2021; 21(3):442-445
    8张凤俊,易敬林,李晶明,等.糖尿病视网膜病变发病机制研究进展.眼科新进展2016; 36(6):584-587
    9史晨旭,杜佳蓉,吴威,等.葛根化学成分及药理作用研究进展.中国现代中药2021; 23(12):2177-2195
    10 施晓伟,刘文,王群,等.葛根芩连汤的研究进展.贵阳中医学院学报2013; 35(1):21-24
    11 孙华, 李春燕, 薛金涛. 葛根的化学成分及药理作用研究进展. 新乡医学院学报 2019; 36(11):1097-1101
    12 楚纪明, 马树运, 李海峰, 等. 葛根有效成分及其药理作用研究进展. 食品与药品 2015; 17(2): 142-146
    13 陈艳, 文佳玉, 谢晓芳, 等. 葛根的化学成分及药理作用研究进展. 中药与临床 2021; 12(1):53-60
    14 Zhou YX, Zhang H, Peng C. Effects of puerarin on the prevention and treatment of cardiovascular diseases. Front Pharmacol 2021; 12:771793
    15 王华玲. 葛根素注射液治疗冠心病不稳定型心绞痛临床疗效观察分析. 中医临床研究 2021; 13(14):43-46
    16 张政国. 葛根素防治蛛网膜下腔出血后脑血管痉挛的临床及实验研究. 中国实用医药 2013; 8(32):147-148
    17 Jiang Z, Cui X, Qu P, et al. Roles and mechanisms of puerarin on cardiovascular disease: a review. Biomed Pharmacother 2022; 147:112655
    18 Xiao L, Zhong MD, Huang Y, et al. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways. Aging 2020; 12(21):21706-21729
    19 郝原青, 郭晓雪, 丁雅珊, 等. 葛根素对大鼠酒精性肝纤维化的干预作用以及对肝星状细胞增殖活化的影响. 天津中医药大学学报 2016; 35(2): 132-135
    20 秦魏,郭蒙,李欣雨,等.中药单体治疗糖尿病视网膜病变的研究进展.国际眼科杂志2021; 21(8):1373-1377
    21 陈放, 刘开扬, 徐珊, 等. 葛根素对STZ诱导的糖尿病大鼠视网膜的保护作用及机制研究. 中国药理学通报 2011; 27(9):1279-1284
    22 Chen F, Zhang HQ, Zhu J, et al. Puerarin enhances superoxide dismutase activity and inhibits RAGE and VEGF expression in retinas of STZ-induced early diabetic rats. Asian Pac J Trop Med 2012; 5(11):891-896
    23 Kim KM, Jung DH, Jang DS, et al. Puerarin suppresses AGEs-induced inflammation in mouse mesangial cells: a possible pathway through the induction of heme oxygenase-1 expression. Toxicol Appl Pharmacol 2010; 244(2):106-113
    24 Yeh CH, Sturgis L, Haidacher J, et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion. Diabetes 2001; 50(6):1495-1504
    25 Yokoi M, Yamagishi SI, Takeuchi M, et al. Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy. Br J Ophthalmol 2005; 89(6):673-675
    26 向雪松, 王竹, 祝宇铭, 等. 链脲佐菌素注射剂量对建立2型糖尿病大鼠模型的影响. 卫生研究 2010; 39(2): 138-142
    27 杜倩, 田秋霞, 付莉萍, 等. 银杏叶提取物对糖尿病大鼠视网膜病变的作用. 中国病理生理杂志 2016; 32(7): 1323-1326
    28 周玮琰, 王洪亚, 杜秀娟, 等. 甘糖酯对糖尿病大鼠视网膜病变中炎性因子 TNF-α和IL-1β表达的影响. 国际眼科杂志 2016; 16(8):1444-1448
    29 杨丽, 常笑语, 石搏. 葛根素对糖尿病大鼠视网膜中IGF-1和TNF-α表达的影响. 中国实验诊断学 2016; 20(5): 697-699
    30 张启明, 王辉. 葛根素对大鼠糖尿病视网膜病变的抑制作用. 眼科新进展 2019; 39(1):22-26
    31 陈放, 徐珊, 吕伟红, 等. 糖尿病大鼠视网膜氧化应激损伤及葛根素的干预作用. 眼科新进展 2012; 32(1):15-19
    32 Hou BY, Zhao YR, Ma P, et al. Hypoglycemic activity of puerarin through modulation of oxidative stress and mitochondrial function via AMPK. Chin J Nat Med 2020; 18(11):818-826
    33 Liang T, Xu X, Ye D, et al. Caspase/AIF/apoptosis pathway: a new target of puerarin for diabetes mellitus therapy. Mol Biol Rep 2019; 46(5):4787-4797
    34 Matsuoka M, Ogata N, Minamino K, et al. Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy. Mol Vis 2007; 13:1058-1065
    35 Olson JA, Whitelaw CM, McHardy KC, et al. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia 1997; 40(10):1166-1171
    36 Zhu X, Xie M, Wang K, et al. The effect of puerarin against IL-1β-mediated leukostasis and apoptosis in retinal capillary endothelial cells(TR-iBRB2). Mol Vis 2014; 20:1815-1823
    37 陈放, 刘开扬, 徐珊, 等. 葛根素对糖尿病大鼠视网膜的保护及对NF-κB表达的抑制. 中国药理学与毒理学杂志 2011; 25(3):296-300
    38 Horvath GL, Schrum JE, De Nardo CM, et al. Intracellular sensing of microbes and danger signals by the inflammasomes. Immunol Rev 2011; 243(1):119-135
    39 Kelley N, Jeltema D, Duan Y, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 2019; 20(13):3328
    40 Lian DW, Yuan HQ, Yin XZ, et al. Puerarin inhibits hyperglycemia-induced inter-endothelial junction through suppressing endothelial Nlrp3 inflammasome activation via ROS-dependent oxidative pathway. Phytomedicine 2019; 55:310-319
    41 Tang D, Kroemer G. Ferroptosis. Curr Biol 2020; 30(21):1292-1297
    42 Singh LP, Yumnamcha T, Devi TS. Mitophagy, Ferritinophagy and Ferroptosis in Retinal Pigment Epithelial Cells Under High Glucose Conditions: Implications for Diabetic Retinopathy and Age-Related Retinal Diseases. JOJ Ophthalmol 2021; 8(5):77-85
    43 Song QT, Zhao Y, Li Q, et al. Puerarin protects against iron overload-induced retinal injury through regulation of iron-handling proteins. Biomed Pharmacother 2020; 122:109690
    44 Meng F, Guo B, Ma YQ, et al. Puerarin: a review of its mechanisms of action and clinical studies in ophthalmology. Phytomedicine 2022; 107:154465
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Hua Zou, Zhi-Peng You, Xiao-Jian Wu. ,/et al.Research progress on the protective effect and mechanism of puerarin on diabetic retinopathy. Guoji Yanke Zazhi( Int Eye Sci) 2023;23(8):1295-1298

Copy
Share
Article Metrics
  • Abstract:3396
  • PDF: 900
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:October 14,2022
  • Revised:July 06,2023
  • Online: July 25,2023